Vaccines have peculiar characteristics as well as their surveillance. Specific requirements, needs and challenges for the vaccine vigilance are discussed in the perspective to improve the whole system in order to guarantee a safer vaccine use and the keeping of the public confidence in vaccinations. Key elements for the routine safety monitoring, new regulations and some available tools are taken into account. Finally, the Italian experience is shortly described.
Keywords: AEFI; Pharmacovigilance; Safety monitoring; Vaccine surveillance; Vaccine vigilance; Vaccines.
Copyright © 2015 Elsevier Ltd. All rights reserved.